Open AccessRelationship between renal anemia and prognostic stages of IgA nephropathy
Author(s) -
Aruga Seiki,
Horiuchi Tomohide,
Shou Ichiyu,
Tashiro Kyouichi,
Kurusu Atsushi,
Fukui Mitsumine,
Horikoshi Satoshi,
Tomino Yasuhiko
Publication year - 2005
Publication title -
journal of clinical laboratory analysis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.536
H-Index - 50
eISSN - 1098-2825
pISSN - 0887-8013
DOI - 10.1002/jcla.20056
Subject(s) - medicine , nephropathy , creatinine , gastroenterology , anemia , peripheral blood , renal function , immunology , endocrinology , diabetes mellitus
Abstract In 2002, the Joint Committee of the Special Study Group on Progressive Glomerular Diseases, Ministry of Health, Labor and Welfare of Japan newly revised the clinical guidelines for IgA nephropathy (Sakai et al.: Jpn J Nephrol 37:417–421, 1995; Tomino and Sakai: Clin Exp Nephrol , 7, 93–97, 2003). The prognostic stages were classified into four groups: the good prognosis group (Group I), relatively good prognosis group (Group II), relatively poor prognosis group (Group III), and poor prognosis group (Group IV). The relationship between the levels of Hb, Ht, and RBC in peripheral blood and the renal prognostic stages was determined in 62 patients with IgA nephropathy in the present study. The mean levels of Hb, Ht, and RBC were significantly lower in Group IV than in Group I ( P <0.05). However, there were no significant changes in the levels of serum creatinine (s‐Cr) or creatinine clearance (CCr) among these four groups. It appears that the levels of Hb, Ht, and RBC in peripheral blood may be important clinical parameters for the evaluation of prognostic stages in patients with IgA nephropathy. J. Clin. Lab. Anal. 19:80–83, 2005. © 2005 Wiley‐Liss, Inc.